{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:51:34Z","timestamp":1772826694983,"version":"3.50.1"},"reference-count":39,"publisher":"IEEE","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/ieeexplore.ieee.org\/Xplorehelp\/downloads\/license-information\/IEEE.html"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.1109\/bibm52615.2021.9669537","type":"proceedings-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:40:30Z","timestamp":1642192830000},"page":"3797-3804","source":"Crossref","is-referenced-by-count":1,"title":["Medication Rule and Mechanism of Action for the Treatment of Polycystic Ovary Syndrome Based on Data Mining and Network Pharmacology"],"prefix":"10.1109","author":[{"given":"Zhiming","family":"Gao","sequence":"first","affiliation":[]},{"given":"Guifang","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Xiaolan","family":"Zou","sequence":"additional","affiliation":[]},{"given":"Lingzhi","family":"Kong","sequence":"additional","affiliation":[]},{"given":"Yuanjun","family":"Zou","sequence":"additional","affiliation":[]}],"member":"263","reference":[{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1061620"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-019-00026-3"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"259s","DOI":"10.1097\/01.ASN.0000077414.59717.74","article-title":"The AGE-RAGE system and diabetic nephropathy.[J]","volume":"14","author":"shigeru","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"107496","DOI":"10.1016\/j.celrep.2020.03.060","article-title":"Progesterone Receptor Serves the Ovary as a Trigger of Ovulation and a Terminator of Inflammation[J]","volume":"31","author":"chan","year":"2020","journal-title":"Cell Reports"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-18-0086"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.10.128"},{"key":"ref37","article-title":"Effects of metformin on the phosphorylation of IRS-1 and P38 in ovarian granulosa cells of PCOS patients [D]","author":"chengfeng","year":"2017","journal-title":"Qingdao University"},{"key":"ref36","article-title":"Polycystic ovary syndrome endometrial lesions and insulin PI3K\/AKT, MAPK\/ERK signaling pathway related research [D]","author":"yanfang","year":"2009","journal-title":"Tianjin Medical University"},{"key":"ref35","article-title":"Studies on sRAGE and GLUT4 in follicular fluid of PCOS patients with or without insulin resistance [D]","author":"liang","year":"2020","journal-title":"Journal of ZhengZhou University"},{"key":"ref34","article-title":"Therapeutic potential of DNA-aptamers raised against AGE-RAGE axis in diabetes-related complications.[J]","author":"sho-ichi","year":"2018","journal-title":"Current Pharmaceutical Design"},{"key":"ref10","first-page":"825","article-title":"Network pharmacological mechanism of action of Gui Ren Wan in the treatment of polycystic ovary syndrome[J]","volume":"32","author":"yan","year":"2021","journal-title":"New Drugs in Chinese Medicine and Clinical Pharmacology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108436"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500326"},{"key":"ref13","first-page":"1","article-title":"Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-?B Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-?B Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages[J]","volume":"2007","author":"h?m?l?","year":"2007","journal-title":"Mediators of Inflammation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.04.023"},{"key":"ref15","article-title":"The Antidiabetic Potential of Quercetin: Underlying Mechanisms[J]","volume":"24","author":"eid","year":"2016","journal-title":"Current Medicinal Chemistry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2017.07.010"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201000005"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.08.011"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1279992"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0116"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4158\/EP15748.DSC"},{"key":"ref27","first-page":"1","article-title":"Expression and localization of HAS2 and PTGS2 in different stages of yak ovary [J]","volume":"49","author":"zechuan","year":"2021","journal-title":"Journal of Northwest A & F University (Natural Science Edition)"},{"key":"ref3","first-page":"981","article-title":"Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications[J]","volume":"2012","author":"evanthia","year":"0","journal-title":"Endocrine Reviews"},{"key":"ref6","first-page":"737","article-title":"The interpretation of Chinese guidelines for diagnosis and treatment of polycystic ovary syndrome [J]","volume":"34","author":"ying","year":"2018","journal-title":"Chin J Practical Gynecol Obstet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201004026"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu012"},{"key":"ref8","first-page":"5","article-title":"To explore the etiology and pathogenesis of traditional Chinese medicine from the ancient name of polycystic ovary syndrome [J]","volume":"33","author":"guifeng","year":"2021","journal-title":"Journal of Jiangxi University of Traditional Chinese Medicine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X17500252"},{"key":"ref2","first-page":"502","article-title":"Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity[J]","author":"zeng","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"ref9","first-page":"694","article-title":"Research progress of traditional Chinese medicine in the treatment of hyperandrogenism in polycystic ovary syndrome [J]","volume":"27","author":"wenjuan","year":"2021","journal-title":"Chinese Journal of Basic Medicine in Traditional Chinese Medicine"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.003"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-015-0887-9"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0400-5"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.03.033"},{"key":"ref24","first-page":"1456","article-title":"The anti-osteoporosis effect and mechanism of isorhamnetin [J]","volume":"36","author":"gao","year":"2016","journal-title":"China Hosp Pharm"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0405"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3153"},{"key":"ref25","first-page":"31","article-title":"Advances in prostaglandin endoperoxidase 2 gene [J]","volume":"2004","author":"xuncui","year":"0","journal-title":"Life Science"}],"event":{"name":"2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","location":"Houston, TX, USA","start":{"date-parts":[[2021,12,9]]},"end":{"date-parts":[[2021,12,12]]}},"container-title":["2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx7\/9669261\/9669139\/09669537.pdf?arnumber=9669537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T16:57:07Z","timestamp":1652201827000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/9669537\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1109\/bibm52615.2021.9669537","relation":{},"subject":[],"published":{"date-parts":[[2021,12,9]]}}}